200 related articles for article (PubMed ID: 32586904)
21. Pharmacologic induction of fetal hemoglobin production.
Atweh G; Fathallah H
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1131-44. PubMed ID: 21075284
[TBL] [Abstract][Full Text] [Related]
22. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
Charache S; Dover G; Smith K; Talbot CC; Moyer M; Boyer S
Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4842-6. PubMed ID: 6192443
[TBL] [Abstract][Full Text] [Related]
23. RN-1, a potent and selective lysine-specific demethylase 1 inhibitor, increases γ-globin expression, F reticulocytes, and F cells in a sickle cell disease mouse model.
Rivers A; Vaitkus K; Ruiz MA; Ibanez V; Jagadeeswaran R; Kouznetsova T; DeSimone J; Lavelle D
Exp Hematol; 2015 Jul; 43(7):546-53.e1-3. PubMed ID: 25931013
[TBL] [Abstract][Full Text] [Related]
24. CRISPR-Cas9 Editing of the
Sharma A; Boelens JJ; Cancio M; Hankins JS; Bhad P; Azizy M; Lewandowski A; Zhao X; Chitnis S; Peddinti R; Zheng Y; Kapoor N; Ciceri F; Maclachlan T; Yang Y; Liu Y; Yuan J; Naumann U; Yu VWC; Stevenson SC; De Vita S; LaBelle JL
N Engl J Med; 2023 Aug; 389(9):820-832. PubMed ID: 37646679
[TBL] [Abstract][Full Text] [Related]
25. A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia.
Gong Y; Zhang X; Zhang Q; Zhang Y; Ye Y; Yu W; Shao C; Yan T; Huang J; Zhong J; Wang L; Li Y; Wang L; Xu X
Blood; 2021 Mar; 137(12):1652-1657. PubMed ID: 33227819
[TBL] [Abstract][Full Text] [Related]
26. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
[TBL] [Abstract][Full Text] [Related]
27. BCL11A-targeted γ-globin gene induction by triterpenoid glycosides of Fagonia indica: A preclinical scientific validation of indigenous herb for the treatment of β-hemoglobinopathies.
Iftikhar F; Khan MBN; Tehreem S; Kanwal N; Musharraf SG
Bioorg Chem; 2023 Nov; 140():106768. PubMed ID: 37586133
[TBL] [Abstract][Full Text] [Related]
28. 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
Dover GJ; Charache SH; Boyer SH; Talbot CC; Smith KD
Prog Clin Biol Res; 1983; 134():475-88. PubMed ID: 6198661
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic induction of PGC-1α stimulates fetal haemoglobin gene expression.
Sun Y; Habara A; Le CQ; Nguyen N; Chen R; Murphy GJ; Chui DHK; Steinberg MH; Cui S
Br J Haematol; 2022 Apr; 197(1):97-109. PubMed ID: 35118652
[TBL] [Abstract][Full Text] [Related]
30. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
[TBL] [Abstract][Full Text] [Related]
31. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
[TBL] [Abstract][Full Text] [Related]
32. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans.
Akinsheye I; Solovieff N; Ngo D; Malek A; Sebastiani P; Steinberg MH; Chui DH
Am J Hematol; 2012 Feb; 87(2):217-9. PubMed ID: 22139998
[TBL] [Abstract][Full Text] [Related]
33. Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations.
Woodard KJ; Doerfler PA; Mayberry KD; Sharma A; Levine R; Yen J; Valentine V; Palmer LE; Valentine M; Weiss MJ
Dis Model Mech; 2022 Jun; 15(6):. PubMed ID: 35793591
[TBL] [Abstract][Full Text] [Related]
34. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
Parker WB; Thottassery JV
J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
[TBL] [Abstract][Full Text] [Related]
35. Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects.
Junker LH; Li B; Zhu X; Koti S; Cerbone RE; Hendrick CL; Sangerman J; Perrine S; Pace BS
Blood Cells Mol Dis; 2022 Mar; 93():102626. PubMed ID: 34856533
[TBL] [Abstract][Full Text] [Related]
36. Development of phenotypic screening assays for γ-globin induction using primary human bone marrow day 7 erythroid progenitor cells.
Li H; Xie W; Gore ER; Montoute MN; Bee WT; Zappacosta F; Zeng X; Wu Z; Kallal L; Ames RS; Pope AJ; Benowitz A; Erickson-Miller CL
J Biomol Screen; 2013 Dec; 18(10):1212-22. PubMed ID: 24163393
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel γ-globin inducers among all potential erythroid druggable targets.
Yu L; Myers G; Schneider E; Wang Y; Mathews R; Lim KC; Siemieniak D; Tang V; Ginsburg D; Balbin-Cuesta G; Singh SA; Phuwakanjana P; Jearawiriyapaisarn N; Khoriaty R; Engel JD
Blood Adv; 2022 Jun; 6(11):3280-3285. PubMed ID: 35240686
[TBL] [Abstract][Full Text] [Related]
38. C2H2 Zinc Finger Transcription Factors Associated with Hemoglobinopathies.
Zhang X; Xia F; Zhang X; Blumenthal RM; Cheng X
J Mol Biol; 2024 Apr; 436(7):168343. PubMed ID: 37924864
[TBL] [Abstract][Full Text] [Related]
39. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
[TBL] [Abstract][Full Text] [Related]
40. Targeting fetal hemoglobin expression to treat β hemoglobinopathies.
Steinberg MH
Expert Opin Ther Targets; 2022 Apr; 26(4):347-359. PubMed ID: 35418266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
